Biomerica, Inc. – $BMRA – Confident Investor Rating: Poor

Company name Biomerica, Inc.
Stock ticker BMRA
Live stock price [stckqut]BMRA[/stckqut]
Confident Investor Rating Poor

The following company description is from Google Finance:
Biomerica, Inc. (Biomerica) develops, manufactures and markets medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. Its medical diagnostic products are sold worldwide in two markets: clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores). Its diagnostic test kits are used to analyze blood or urine from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which may exist in the human body in extremely small concentrations. The Company?s clinical laboratory diagnostic products include tests for bone and anemia conditions, gastrointestinal diseases, food intolerance, diabetes and others.

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. It is not possible to confidently invest in a company that is not currently profitable.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.